John G Robbins

US Patent:

20110212125, Sep 1, 2011

Filed:

Aug 14, 2009

Appl. No.:

13/059051

Inventors:

John B. Robbins - New York NY, US
Rachel Schneerson - Bethesda MD, US
Christopher P. Mocca - Columbia MD, US
Evguenii Vinogradov - Ottawa, CA

International Classification:

A61K 39/385
C07K 14/765
C07K 14/34
A61P 31/04
A61P 37/04

US Classification:

42419711, 530363, 530350

Abstract:

Disclosed are immunogenic conjugates and therapeutic compositions that include such immunogenic conjugates. Also disclosed are methods of treating and/or inhibiting an infection. The disclosed immunogenic conjugates have the general structure:wherein Pr is a carrier protein, Sr is an optional spacer moiety, Kdo is an 3-deoxy-D-manno-octulosonic acid or a derivative thereof, and OS is an oligosaccharide or polysaccharide obtained from In specific examples, the immunogenic conjugates include the core oligosaccharide obtained from having the structure:In specific examples, the disaccharide repeat unit included in the immunogenic conjugate has the structure:

US Patent:

20130216570, Aug 22, 2013

Filed:

Apr 25, 2013

Appl. No.:

13/870547

Inventors:

The United States of America, as represented by the Secretary, Department of Health and Human Services - , US
New York University - , US
John B. Robbins - New York NY, US
Fathy Majadly - Frederick MD, US
Christopher P. Mocca - Columbia MD, US
Jerry Keith - Olney MD, US
Louis Miller - Cabin John MD, US
Ruth Nussenzweig - New York NY, US
Darrell T. Liu - Bethesda MD, US

Assignee:

New York University - New York NY
Services - Bethesda MD

International Classification:

C07K 14/00

US Classification:

4241931, 530363, 530367, 530350

Abstract:

Disclosed are immunogenic conjugates which elicit an immune response to proteins. In particular examples, the proteins include sexual stage surface proteins, circumsporozoite protein (CSP), or immunogenic portions of CSP. Also provided herein are immunogenic compositions including one or more of the disclosed immunogenic conjugates and a pharmaceutically acceptable carrier. Further provided is a method of eliciting an immune response to in a subject, comprising administering to the subject an immunogenic composition disclosed herein.

US Patent:

50686500, Nov 26, 1991

Filed:

Jun 11, 1990

Appl. No.:

7/536028

Inventors:

Antonio Fernandez - Brooklyn NY
Hugo Pineiro Gaggioni - Randolph NJ
Martin J. Jaquez - San Diego CA
John D. Robbins - Mountain Lakes NJ
E. Scott Soper - Morristown NJ

Assignee:

Bell Communications Research, Inc. - Livingston NJ

International Classification:

G09G 102
H04N 5262

US Classification:

340799

Abstract:

A system for combining a plurality of video signals and various forms of still imagery such as text or graphics into a single high resolution display is disclosed. The inventive system utilizes a multiport memory and a key based memory access system to flexibly compose a multiplicity of video signals and still images into a full color high definition television display comprising a plurality of overlapping windows.

US Patent:

49472577, Aug 7, 1990

Filed:

Oct 4, 1988

Appl. No.:

7/253269

Inventors:

Antonio Fernandez - Brooklyn NY
Hugo P. Gaggioni - Randolph NJ
Martin J. Jaquez - San Diego CA
John D. Robbins - Mountain Lakes NJ
E. Scott Soper - Morristown NJ

Assignee:

Bell Communications Research, Inc. - Livingston NJ

International Classification:

H04N 5262

US Classification:

358183

Abstract:

A system for combining a plurality of video signals and various forms of still imagery such as text or graphics into a single high resolution display is disclosed. The invention system utilizes a multiport memory and a key based memory access system to flexibly compose a multiplicity of video signals and still images into a full color high definition television display comprising a plurality of overlapping windows.

US Patent:

57078220, Jan 13, 1998

Filed:

Aug 22, 1994

Appl. No.:

8/294189

Inventors:

Vincent A. Fischetti - W. Hempstead NY
Jasna Rakonjac - New York NY
John Robbins - New York NY

Assignee:

The Rockefeller University - New York NY

International Classification:

C12Q 134
C12N 952
C12N 1557

US Classification:

435 23

Abstract:

Methods and compositions are provided for cloning and expression of serum opacity factor of Streptococcus pyogenes genes. The portion produced by the recombinant DNA techniques described herein may be employed in qualitative and quantitative testing for high density lipoprotein, as a fibronectin binding factor and for the regulation of high density lipoprotein in a mammal. The gene may further be employed as a molecular probe for accurate identification of opacity factors from various strains of Streptococcus pyogenes.